Evidence map›Paper›PMID 42787159›Full record

ArticleFrontiers in endocrinology2026

Biallelic

Tao Wang, Qian Zhang, Tingting Shi, Xin Chen, Li Wang, Xiuming Liu, Yihui Wang, Kaikai Shen, Fei Zhao, Litao Qin

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tao Wang *Medical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Qian Zhang *Medical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Tingting Shi *Medical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Xin ChenMedical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Li WangMedical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Xiuming LiuMedical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Yihui WangMedical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Kaikai ShenDepartment of Ultrasound, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Fei ZhaoDepartment of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Litao QinMedical Genetic Institute of Henan Province, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Pathogenic variants in the Methods: We evaluated two affected individuals from the same family presenting with both PHO and possible CEAS. Next, a systematic literature review was conducted across the PUBMED, EMBASE, and China National Knowledge Infrastructure (CNKI) databases, covering the period from January 1, 2000, to November 30, 2025. Clinical and genetic data from the literature cohort and our index were collected and analyzed. Results: Two novel compound heterozygous variants (NM_005630.3: c.232G>T and c.1929C>G) in the Conclusions: This study identified two novel compound heterozygous variants (NM_005630.3: c.232G>T and c.1929C>G) in

Indexed as

Intestinal DiseasesMutationOrganic Anion TransportersOsteoarthropathy, Primary HypertrophicAllelesChronic DiseaseFemaleHumansMalePedigreePhenotypeSiblingsOrganic Anion TransportersSLCO2A1 protein, humanbiallelic variantschronic enteropathy associated with SLCO2A1 genegenotype-phenotype correlationprimary hypertrophic osteoarthropathySLCO2A1

Identifiers

PMID42787159
PMCPMC13600845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.